More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene
Older Women More Likely To Receive Lower Chemotherapy Doses, Study Finds
ASTRO Issues Statement On APBI For Breast Cancer
Denosumab Demonstrates Superiority Over Zometa For Bone Metastases
Lymphedema Education Helps Reduce Symptoms, Study Finds
Exercise May Help Combat Leukemia Patients’ Fatigue
Cranial Radiation Eliminated With Personalized Chemo
Young Early-Stage Patients Can Preserve Fertility
Limb-Sparing Surgery May Not Offer Better Quality of Life
AIDS Patients Face Higher Risk Of HPV-Related Cancers As Immunosuppression Grows
Budesonide Not Beneficial For Diarrhea In Melanoma
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer patients with Medicare Advantage have access to fewer providers than Medicare patients, cross-sectional study finds
- A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.
The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m. - Did peer review fail? Nature Medicine’s chronotherapy paper retraction raises questions
- A new diagnostic lens—and a lasting scientific legacy
- OMB’s plan to increase political control of science faces stiff opposition on Capitol Hill
